|
1
|
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer.
|
Int J Nanomedicine
|
2009
|
1.93
|
|
2
|
Long-term survival in metastatic pancreatic cancer. A case report and review of the literature.
|
JOP
|
2006
|
1.06
|
|
3
|
MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.
|
Am J Obstet Gynecol
|
2008
|
0.99
|
|
4
|
Breast adenomyoepithelioma: a case report with malignant proliferation of epithelial and myoepithelial elements.
|
World J Surg Oncol
|
2013
|
0.98
|
|
5
|
A comparative analysis of serum and serum-free media for generation of clinical grade DCs.
|
J Immunother
|
2007
|
0.96
|
|
6
|
Immunologic treatments for precancerous lesions and uterine cervical cancer.
|
J Exp Clin Cancer Res
|
2014
|
0.96
|
|
7
|
The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site.
|
World J Surg Oncol
|
2008
|
0.94
|
|
8
|
Thyroid dysfunction and tyrosine kinase inhibitors in renal cell carcinoma.
|
Endocr Relat Cancer
|
2013
|
0.91
|
|
9
|
Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
|
J Exp Clin Cancer Res
|
2008
|
0.90
|
|
10
|
Late breast cancer recurrence to the uterine cervix with a review of the literature.
|
Int J Gynecol Pathol
|
2008
|
0.88
|
|
11
|
Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view.
|
J Clin Oncol
|
2012
|
0.87
|
|
12
|
Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy.
|
Oncology
|
2016
|
0.86
|
|
13
|
Breast cancer metastatic to the pituitary gland: a case report.
|
World J Surg Oncol
|
2012
|
0.81
|
|
14
|
Tumor-derived microvesicles: the metastasomes.
|
Med Hypotheses
|
2012
|
0.81
|
|
15
|
A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report.
|
J Med Case Rep
|
2013
|
0.80
|
|
16
|
Triple-negative breast cancer: investigating potential molecular therapeutic target.
|
Expert Opin Ther Targets
|
2014
|
0.80
|
|
17
|
Cervical cancer: are there potential new targets? An update on preclinical and clinical results.
|
Curr Drug Targets
|
2014
|
0.79
|
|
18
|
Intraperitoneal chemotherapy by ultrasound-guided direct puncture in recurrent ovarian cancer: feasibility, compliance, and complications.
|
Int J Gynecol Cancer
|
2012
|
0.79
|
|
19
|
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.
|
Crit Rev Oncol Hematol
|
2011
|
0.79
|
|
20
|
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.
|
Mol Cancer Ther
|
2014
|
0.78
|
|
21
|
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
|
J Exp Clin Cancer Res
|
2013
|
0.78
|
|
22
|
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study.
|
Ther Clin Risk Manag
|
2013
|
0.78
|
|
23
|
Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study.
|
J Ovarian Res
|
2014
|
0.77
|
|
24
|
Breast cancer risk after exposure to fertility drugs.
|
Expert Rev Anticancer Ther
|
2013
|
0.77
|
|
25
|
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
|
Cancer Chemother Pharmacol
|
2010
|
0.77
|
|
26
|
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.
|
Tumori
|
2015
|
0.77
|
|
27
|
A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer.
|
BMC Cancer
|
2006
|
0.77
|
|
28
|
Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.
|
J Clin Oncol
|
2012
|
0.76
|
|
29
|
Epistaxis in weekly paclitaxel regimen: Is it really related to schedule?
|
Basic Clin Pharmacol Toxicol
|
2010
|
0.75
|
|
30
|
An update of laparoscopy in cervical cancer staging: is it a useful procedure?
|
Oncology
|
2013
|
0.75
|
|
31
|
Hot flushes in women with breast cancer: state of the art and future perspectives.
|
Expert Rev Anticancer Ther
|
2013
|
0.75
|
|
32
|
[Aromatase inhibitors in advanced breast cancer].
|
Recenti Prog Med
|
2008
|
0.75
|
|
33
|
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan.
|
Arch Gynecol Obstet
|
2014
|
0.75
|
|
34
|
Vulvodynia: current opinion and treatment strategies.
|
Minerva Ginecol
|
2015
|
0.75
|
|
35
|
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions.
|
Chemotherapy
|
2016
|
0.75
|